Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies

Nephrology Dialysis Transplantation

Volumn 33, Issue 2, 2018, Pages 310-318

  Mariani, Laura H ^a   Martini, Sebastian ^a   Barisoni, Laura ^b   Canetta, Pietro A ^c   Troost, Jonathan P ^a   Hodgin, Jeffrey B ^a   Palmer, Matthew ^d   Rosenberg, Avi Z ^e   Lemley, Kevin V ^f   Chien, Hui Ping ^e   Zee, Jarcy ^g   Smith, Abigail ^g   Appel, Gerald B ^c   Trachtman, Howard ^h   Hewitt, Stephen M ⁱ   Kretzler, Matthias ^a   Bagnasco, Serena M ^e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^h NEW YORK UNIVERSITY   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

gene expression; interstitial fibrosis; kidney biopsy; proteinuria

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ADULT; ANTIGEN PRESENTATION; ARTICLE; DIGITAL IMAGING; DISEASE ACTIVITY; DISEASE EXACERBATION; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FIBROSING ALVEOLITIS; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; SCORING SYSTEM; BIOPSY; DIAGNOSTIC IMAGING; FIBROSIS; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; INTERSTITIAL NEPHRITIS; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

ADULT; BIOPSY; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; MALE; NEPHRITIS, INTERSTITIAL; PATHOLOGY, CLINICAL; PROGNOSIS; PROTEINURIA; SURVIVAL RATE; YOUNG ADULT;

EID: 85041665200     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw443     Document Type: Article

References (42)

1. Striker GE, Schainuck LI, Cutler RE et al. Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970; 1: 615-630
2. Schainuck LI, Striker GE, Luther RE et al. Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1970; 1: 631-641
3. Bohle A, Mackensen-Haen S, von Giese H et al. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990; 186: 135-144
4. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
5. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria-An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714
6. Solez K, Axelsen R, Benedicktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422
7. Haas M, Sis B, Racusen LC et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-Associated arterial lesions. Am J Transplant 2014; 14: 272-283
8. Cattran D, Coppo R, Cook H et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545
9. Austin III HA, Muenz LR, Joyce KMet al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am JMed 1983; 75: 382-391
10. DAgati VD, Fogo AB, Brujin JA et al. Pathological classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 2004; 43: 368-382
11. Weening JJ, DAgati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250
12. Berden AE, Ferrario F, Hagen EC et al. Histopathologic classification of ANCA-Associated glomerulonephritis. J AmSocNephrol 2010; 21:1628-1636
13. Tervaert TWC, Mooyaart AL, Amann K et al. Pathologic classification of diabetic nephropathy. J AmSoc Nephrol 2010; 21: 556-563
14. Haas M, Rastaldi MP, Fervenza FC. Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int 2014; 85: 779-793
15. Sethi S, Haas M, Markowitz GS et al. Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol 2016; 29: 671-684
16. Barisoni L, Troost JP, Nast C et al. Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images.Mod Pathol 2016
17. Gadegbeku CA, Gipson DS, Holzman LB et al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 2013; 83: 749-756
18. Barisoni L, Nast CC, Jennette JC et al. Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol 2013; 8: 1449-1459
19. Rosenberg AZ, Palmer M, Merlino L et al. The application of digital pathology to improve accuracy in glomerular enumeration in renal biopsies. PLoS ONE 2016; 11: e0156441
20. Nast CC, Lemley KV, Hodgin JB et al. Morphology in the digital age: integrating high-resolution description of structural alterations with phenotypes and genotypes. Semin Nephrol 2015; 35: 266-278
21. Levey AS, Inker LA, Matsushita K et al. GFR decline as an end point for clinical trials in ckd: A scientific workshop sponsored by the national kidney foundation and the US Food and drug administration. Am J Kidney Dis 2014; 64: 821-835
22. Gipson DS, Troost JP, Lafayette RA et al. Complete remission in the Nephrotic Syndrome Study Network. Clin J Am Soc Nephrol 2016; 11: 81-89
23. Lai JY, Luo J, OConnor C et al. MicroRNA-21 in glomerular injury. J Am Soc Nephrol 2015; 26: 805-816
24. Schmid H, Boucherot A, Yasuda Y et al. Modular Activation of Nuclear Factor-jB Transcriptional Programs in Human Diabetic Nephropathy. Diabetes 2006; 55: 2993-3003
25. Farris AB, Adams CD, Brousaides N et al. Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol 2011; 22: 176-186
26. Farris AB, Alpers CE. What is the best way to measure renal fibrosis?: A pathologists perspective. Kidney Int Suppl 2014; 4: 9-15
27. Sund S, Grimm P, Reis?er AV et al. Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis. Nephrol Dial Transplant 2004; 19: 2838-2845
28. Lemley KV, Bagnasco SM, Nast CC et al. Morphometry predicts early GFR change in primary proteinuric glomerulopathies: A longitudinal cohort study using generalized estimating equations. PLoS ONE 2016; 11: e0157148
29. DAmico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237
30. Barbour SJ, Espino-Hernandez G, Reich HN et al. TheMEST score provides earlier risk prediction in lgA nephropathy. Kidney Int 2016; 89: 167-175
31. Mise K, Hoshino J, Ueno T et al. Prognostic value of tubulointerstitial lesions, urinary n-Acetyl-b-d-glucosaminidase, and urinary b2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. Clin J AmSoc Nephrol 2016; 11: 593-601
32. Zuo K, Wu Y, Li S-J et al. Long-Term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population. Clin Nephrol 2013; 79: 445-453
33. Kremers WK, Denic A, Lieske JC et al. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: The Aging Kidney Anatomy study. Nephrol Dial Transplant 2015; 30: 2034-2039
34. Henger A, KretzlerM, Doran P et al. Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression1. Kidney Int 2004; 65: 904-917
35. Hotchiss H, Chu T, Hancock W et al. Differential expression of profibrotic and growth factors in chronic allograft nephropathy. Transplantation 2006; 81: 342-349
36. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217
37. Campanholle G, Ligresti G, Gharib SA et al. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol 2013; 304: C591-C603
38. Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 2014; 124: 2299-2306
39. JuW, Nair V, Smith S et al. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med 2015; 7: 316ra193
40. Sonoda Y, Gohda T, Suzuki Y et al. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. PLoS ONE 2015; 10: e0122212
41. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760
42. Mannon RB, Matas AJ, Grande J et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: A potent predictor of allograft failure. Am J Transplant 2010; 10: 2066-2073